Article L4331-2-1
…nt year, the first payment being made before 31 January.When the amount to be allocated cannot be determined as indicated above, the monthly allocations are made up to one-twelfth of the amount of tax…
20+ full codes, 2,400+ articles translated and updated. Case law linked to every article. Read the actual text before you ask a lawyer about it — free, no login required.
20+
french codes
Fully translated
2,400+
articles in English
Updated regularly
480+
court rulings linked
Per article
Free
full access
No login required
Showing 5391–5400 of 69883 articles for “Art. I-1°-a ter”
…nt year, the first payment being made before 31 January.When the amount to be allocated cannot be determined as indicated above, the monthly allocations are made up to one-twelfth of the amount of tax…
…mme for the prevention of occupational risks and the improvement of working conditions which : a) Determines the detailed list of measures to be taken in the coming year, including measures to prevent…
…sation holder of the reference biological medicinal product.The Director General of the Agency registers the similar biological medicinal product in the reference list of similar biological groups pro…
…tion of a proprietary medicinal product shall mention its active ingredients, designated by their international non-proprietary name recommended by the World Health Organisation or, failing this, thei…
The holder of an intellectual property right protecting the appearance and texture of the oral pharmaceutical forms of a reference medicinal product within the meaning of Article L. 5121-1 may not pro…
…thorisations, the Agence nationale de sécurité du médicament et des produits de santé may, in the interests of public health, prohibit the prescription and supply of a proprietary medicinal product an…
…ts website the designation of the active ingredients of this medicinal product according to their international non-proprietary name recommended by the World Health Organisation or, failing this, thei…
The company which exploits a proprietary medicinal product contributes to its proper use by ensuring in particular that the product is prescribed in compliance with its marketing authorisation referre…
Where a medicinal product is authorised in another Member State of the European Union or a State party to the Agreement on the European Economic Area, but is not the subject in France of either the ma…
…n (EC) No 726/2004, mentions the active ingredients of the medicinal product, designated by their international non-proprietary name recommended by the World Health Organisation or, failing this, by t…
Avocate au Barreau de Paris
Toque #C2396
15+ Years In French Corporate Practice
English · French · Russian
Ready When You Are
A 20–30 minute call, in English, to scope the engagement. No obligation, no preliminary fee. You will leave the call with a clear view of what the work will cover and what it will cost.
20+ full codes and 2,400+ articles in English, with the key court rulings linked to every article — free to read.
Read MoreA lawyer-reviewed report explaining how the relevant articles apply to your situation, with case-law analysis and next steps.
Read MoreScope your matter with a Paris-Bar avocate — incorporation, contracts, disputes — handled bilingually, end to end.
Read More